In our study, the subchronic treatment with fenofibrate and metformin, at low doses, lowers the hyperglycemia but does not improve the glucose tolerance in DB-rats compared with CT-rats, an effect most probably mediated by PPARα. This evidence concerns the gene PPARA and Hyperglycemia.